ConductScience.org, home

Comparison · NCT03488108-51c63c37

Platelet Rich Plasma vs Minoxidil Foam: Adverse Event of Redness on Scalp

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Platelet Rich Plasma vs Minoxidil Foam: Adverse Event of Redness on Scalp. Trial comparisons, record NCT03488108-51c63c37. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03488108-51c63c37

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 1000.168wilson
Risk in group 2000.168wilson
Risk difference, group 1 minus group 20-0.1680.168newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treatfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Platelet Rich PlasmaSubjects who received PRP in either the first or last 12 weeks of the study019OG000
Group 2Minoxidil FoamSubjects who received Minoxidil either the first or last 12 weeks of the study019OG001

Outcome

Type
SECONDARY
Title
Adverse Event of Redness on Scalp
Description
Total number of participants experiencing Redness on Scalp was measured after both interventions, in each Arm/Group.
Time frame
after 12 weeks of treatment
Population

Source ClinicalTrials.gov

Trial

Title
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
NCT number
NCT03488108
Phases
PHASE1, PHASE2
Conditions
Alopecia
Interventions
Platelet Rich Plasma, Minoxidil Foam
Lead sponsor
Mayo Clinic
Results first posted
2020-04-08

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03488108-51c63c37